SK pharmteco in the news
API cell gene therapy
Tamtam found 7 recent articles about SK pharmteco.
- SK pharmteco to invest $180 million in expansions in Rancho Cordova, El Dorado Hills
SK pharmteco is investing $180 million to expand its facilities in Rancho Cordova and El Dorado Hills, creating 100 jobs.
- SK pharmteco commits $200m to US small molecule and peptide manufacturing expansion
SK pharmteco is investing over $200 million in the US to expand its small molecule and peptide manufacturing, creating 100 jobs and upgrading facilities to meet demand.
- SK pharmteco to Invest Over $200M in U.S. Over Next 5 Years
SK pharmteco will invest over $200 million in its U.S. facilities over five years to boost small molecule and peptide production and create 100 jobs.
- SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
SK pharmteco is investing over $200 million to expand its U.S. small molecule and peptide manufacturing capabilities, creating 100 jobs.
- Exclusive: SK pharmteco unveils $200M+ investment to expand CDMO capabilities
SK pharmteco will invest more than $200 million over five years to expand its manufacturing capabilities.
- SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
SK pharmteco provides manufacturing support for GEMMABio's CHARISMA trial, a clinical study for a next-generation gene therapy treating Spinal Muscular Atrophy Type 1.
- The SK pharmteco Three-Business-Unit Strategy: Small Molecules, Peptides, and Viral Vectors
SK pharmteco is investing $100 million in its cell and gene therapy division, leveraging its global manufacturing and decentralized culture, while preparing for AI integration and regionalized supply chains.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like SK pharmteco?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies